Back to search

Massachusetts Institute of Technology

Product quality regulation and innovation in the pharmaceutical industry.

Abstract

dc:description.abstract

This thesis examines the effect that federal regulation of the product quality of new drugs (through safety and efficacy requirements) has had on the flow of new drugs onto the market place. The approach is to econometrically estimate these effects using disaggregated therapeutic class data from the 1970's. There are two primary estimations. First, the current effects of regulation on the production function relation between introductions and research expenditures are estimated. Second, the indirect effects of regulation on research effort are estimated in a research expenditures equation. These estimates are then combined to estimate the overall effect of regulation on introductions in the current era. In addition to the basic estimations described above, several important subsidiary issues are treated in the thesis. One is a discussion of the decline in new drug introductions of the 1962 era in terms of its individual therapeutic class components. This discussion gives strong support to the position that nonregulatory factors precipitated that decline in the rate of product introductions. Also, the project selection process of major pharmaceutical companies is examined in great detail. That discussion, and some econometric tests of hypotheses generated, clearly demonstrates that in order to predict how firms will respond to changes in environmental factors affecting profitability, one must first understand how firms collect, evaluate, and apply information concerning those factors.

Degree

thesis:*
Department dc:contributor.department
Massachusetts Institute of Technology. Dept. of Economics
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
1979

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Wiggins, Steven N.
Advisor dc:contributor.advisor
  • Peter Temin.

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1721.1/16319
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/16319

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
related terms
citation

Wiggins, Steven N.. Product quality regulation and innovation in the pharmaceutical industry.. Massachusetts Institute of Technology, 1979. http://hdl.handle.net/1721.1/16319